Pacific Air Cargo Purchases Implant Sciences' QS-B220 Explosives Trace Detector for Air Cargo Screening
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today that Pacific Air Cargo has purchased its first QS-B220™ desktop explosives trace detector (ETD). This sale is the most recent in a series of orders resulting from Implant Sciences exhibiting its QS-B220 explosives trace detector at Air Cargo 2013.
Air Cargo 2013 took place in March 2013 and is the premier annual trade show and conference for the AEMCA (Air & Expedited Motor Carriers Association), the AfA (Airforwarders Association), the XLA (Express Delivery & Logistics Association), and ACI-NA (Airports Council International - North America), all of whom co-host Air Cargo as a service to the industry.
Global C4ISR Market Assessment
Pacific Air Cargo CEO, Beti Ward, commented, "We heard about the QS-B220 from a colleague who attended Air Cargo, where they saw the QS-B220 demo and were very impressed. After evaluating the QS-B220's performance metrics and total cost of ownership, it was clear to us that this is the TSA-qualified ETD we want to use at Pacific Air Cargo."
"Air cargo purchasers who get exposure and familiarity with our QS-B220 see the clear value in our ETD and this directly results in purchases. Attending industry trade shows is a key component of our sales and marketing strategy. This is the most recent in a series of orders that resulted from Air Cargo 2013 and we look forward to participating in Air Cargo 2014 this year," commented Implant Sciences' Vice President of Sales and Marketing, Dr. Darryl Jones.
Founded in 2000, Pacific Air Cargo (PAC) possesses extensive experience and maintains an outstanding success record servicing the Honolulu and Pacific region cargo market. The loyalty and confidence of PAC's customers has resulted in the annual shipment of more than 80 million pounds of cargo and has allowed them to be one of the fastest growing companies in the industry.
Source : Implant Sciences Corporation
Dec 9, 2014 - London, United Kingdom
Nov 5 - 6, 2014 - Washington, United States